nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A cost-consequence analysis of adding pertuzumab to the neoadjuvant combination therapy in HER2-positive high-risk early breast cancer in Italy
|
Zambelli, Alberto |
|
|
71 |
C |
p. 113-121 |
artikel |
2 |
Adenosquamous proliferation in radial sclerosing lesions: Histologic spectrum and key features in systematic review of 247 lesions
|
Bachert, S. Emily |
|
|
71 |
C |
p. 99-105 |
artikel |
3 |
Aesthetic results were more satisfactory after oncoplastic surgery than after total breast reconstruction according to patients and surgeons
|
Araújo Pereira Lisboa, Fabiana Christina |
|
|
71 |
C |
p. 47-53 |
artikel |
4 |
Agreement on risk assessment and chemotherapy recommendations among breast cancer specialists: A survey within the MINDACT cohort
|
Lopes Cardozo, Josephine M.N. |
|
|
71 |
C |
p. 143-149 |
artikel |
5 |
Analysis of the association of HER-2 low carcinomas and PAM50 assay in hormone receptor positive early-stage breast cancer
|
Terán, Santiago |
|
|
71 |
C |
p. 42-46 |
artikel |
6 |
Barrier films for the prevention of acute radiation dermatitis in breast cancer: A systematic review and meta-analysis of randomised controlled trials
|
Dejonckheere, Cas Stefaan |
|
|
71 |
C |
p. 31-41 |
artikel |
7 |
Brain metastasis in de novo stage IV breast cancer
|
He, Yaning |
|
|
71 |
C |
p. 54-59 |
artikel |
8 |
Breast cancer deaths attributable to alcohol consumption: Italy, 2015–2019
|
Driutti, Marco |
|
|
71 |
C |
p. 96-98 |
artikel |
9 |
Breast cancer survival and incidence of second primary cancers after 30 years in a randomized study of two versus five years of adjuvant tamoxifen therapy
|
Nordenskjöld, Anna |
|
|
71 |
C |
p. 63-68 |
artikel |
10 |
Differences between the efficacy of HER2(2+)/FISH-positive and HER2(3+) in breast cancer during dual-target neoadjuvant therapy
|
Chen, Wei |
|
|
71 |
C |
p. 69-73 |
artikel |
11 |
Direct and indirect effects of COVID-19 on short-term mortality of breast cancer patients
|
Di Cosimo, Serena |
|
|
71 |
C |
p. 60-62 |
artikel |
12 |
Does mammographic density predict survival in women with invasive breast cancer? The need to account for potential confounding from cancer stage and overdiagnosis
|
Bell, Katy JL. |
|
|
71 |
C |
p. 29-30 |
artikel |
13 |
Editorial Board
|
|
|
|
71 |
C |
p. i |
artikel |
14 |
Effect of high-dose radiation therapy on positive margins after breast-conserving surgery for invasive breast cancer
|
Kim, Hyunjung |
|
|
71 |
C |
p. 106-112 |
artikel |
15 |
Efficacy of probiotics and trimebutine maleate for abemaciclib-induced diarrhea: A randomized, open-label phase II trial (MERMAID, WJOG11318B)
|
Masuda, Hiroko |
|
|
71 |
C |
p. 22-28 |
artikel |
16 |
Explaining risks and benefits of loco-regional treatments to patients
|
Beltran-Bless, Ana-Alicia |
|
|
71 |
C |
p. 132-137 |
artikel |
17 |
Impact of body mass index and its change on survival outcomes in patients with early breast cancer: A pooled analysis of individual-level data from BCIRG-001 and BCIRG-005 trials
|
Chen, Haizhu |
|
|
71 |
C |
p. 1-12 |
artikel |
18 |
Individualising radiation therapy decisions in breast cancer patients based on tumour infiltrating lymphocytes and genomic biomarkers
|
Machiels, Melanie |
|
|
71 |
C |
p. 13-21 |
artikel |
19 |
‘PartBreCon’ study. A UK multicentre retrospective cohort study to assess outcomes following PARTial BREast reCONstruction with chest wall perforator flaps
|
Agrawal, A. |
|
|
71 |
C |
p. 82-88 |
artikel |
20 |
Patient-reported health-related quality of life outcomes following mastectomy for breast cancer, with immediate, delayed or no breast reconstruction: Four-year follow-up from a prospective cohort study
|
Dempsey, Kathy |
|
|
71 |
C |
p. 122-131 |
artikel |
21 |
The natural history of ductal carcinoma in situ (DCIS) in simulation models: A systematic review
|
Poelhekken, Keris |
|
|
71 |
C |
p. 74-81 |
artikel |
22 |
The role of CDK4/6 inhibitors in older and younger patients with breast cancer: A systematic review and meta-analysis
|
Petrelli, Fausto |
|
|
71 |
C |
p. 138-142 |
artikel |
23 |
This house believes that: MARI/TAD is better than sentinel node biopsy after PST for cN+ patients
|
van Hemert, Annemiek K.E. |
|
|
71 |
C |
p. 89-95 |
artikel |